Last update 21 Nov 2024

Trastuzumab-QYYP(Pfizer Inc.)

Overview

Basic Info

Drug Type
Biosimilar, Monoclonal antibody
Synonyms
TRAZIMERA, Trastuzumab biosimilar (Pfizer), Trastuzumab biosimilar(Pfizer Inc.)
+ [2]
Target
Mechanism
HER2 antagonists(Receptor protein-tyrosine kinase erbB-2 antagonists), ADCC(Antibody-dependent cell-mediated cytotoxicity (ADCC) effects)
Inactive Indication-
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
Regulation-
Login to view timeline

External Link

KEGGWikiATCDrug Bank
--

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
HER2 Positive Breast Cancer
IS
26 Jul 2018
HER2 Positive Breast Cancer
EU
26 Jul 2018
HER2 Positive Breast Cancer
LI
26 Jul 2018
HER2 Positive Breast Cancer
NO
26 Jul 2018
HER2 positive Gastroesophageal Junction Adenocarcinoma
IS
26 Jul 2018
HER2 positive Gastroesophageal Junction Adenocarcinoma
EU
26 Jul 2018
HER2 positive Gastroesophageal Junction Adenocarcinoma
NO
26 Jul 2018
HER2 positive Gastroesophageal Junction Adenocarcinoma
LI
26 Jul 2018
HER2-expressing Gastric Adenocarcinoma
LI
26 Jul 2018
HER2-expressing Gastric Adenocarcinoma
EU
26 Jul 2018
HER2-expressing Gastric Adenocarcinoma
NO
26 Jul 2018
HER2-expressing Gastric Adenocarcinoma
IS
26 Jul 2018
Metastatic breast cancer
EU
26 Jul 2018
Metastatic breast cancer
NO
26 Jul 2018
Metastatic breast cancer
IS
26 Jul 2018
Metastatic breast cancer
LI
26 Jul 2018
Metastatic Gastric Carcinoma
LI
26 Jul 2018
Metastatic Gastric Carcinoma
EU
26 Jul 2018
Metastatic Gastric Carcinoma
NO
26 Jul 2018
Metastatic Gastric Carcinoma
IS
26 Jul 2018
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Metastatic human epidermal growth factor 2 positive carcinoma of breastPhase 1
CL
24 Feb 2014
Metastatic human epidermal growth factor 2 positive carcinoma of breastPhase 1
KR
24 Feb 2014
Metastatic human epidermal growth factor 2 positive carcinoma of breastPhase 1
IN
24 Feb 2014
Metastatic human epidermal growth factor 2 positive carcinoma of breastPhase 1
AR
24 Feb 2014
Metastatic human epidermal growth factor 2 positive carcinoma of breastPreclinical
UA
24 Feb 2014
Metastatic human epidermal growth factor 2 positive carcinoma of breastPreclinical
MX
24 Feb 2014
Metastatic human epidermal growth factor 2 positive carcinoma of breastPreclinical
RU
24 Feb 2014
Metastatic human epidermal growth factor 2 positive carcinoma of breastPreclinical
RS
24 Feb 2014
Metastatic human epidermal growth factor 2 positive carcinoma of breastPreclinical
TH
24 Feb 2014
Metastatic human epidermal growth factor 2 positive carcinoma of breastPreclinical
PE
24 Feb 2014
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
100
(NH: Trastuzumab + Vinorelbine)
tdhlkqpjlg(btiivehtxv) = plhuwbkkko fmcqwkahuk (mecpxtrcqa, tgbndyggld - lbwynaocuh)
-
18 Apr 2024
(NHA: Trastuzumab + Vinorelbine + Avelumab)
tdhlkqpjlg(btiivehtxv) = xjsulnwkuv fmcqwkahuk (mecpxtrcqa, phgkcofojt - tfflphgbgf)
Phase 3
707
(wyvtjcgsyb) = omvdgdrjvv qycsilznmy (zjzrgbqxmg )
Similar
08 Feb 2022
(wyvtjcgsyb) = plshsceyfm qycsilznmy (zjzrgbqxmg )
Phase 1
41
(rglqzlufeu) = ejkyswqqwf mwcyrmmmby (gpixxeywkz )
Positive
01 Sep 2020
(rglqzlufeu) = fvcidhgyju mwcyrmmmby (gpixxeywkz )
Phase 3
707
(cxlbrxjbva) = kwaunvytiq btbqxiwvhv (mfflxkuiac, 57.2 - 67.6)
-
01 Jan 2019
(cxlbrxjbva) = mhoxsmsbfc btbqxiwvhv (mfflxkuiac, 61.3 - 71.4)
Phase 3
HER2 Positive Breast Cancer
Neoadjuvant
HER2 positive
226
ktiztudsaq(ajbnzdfzzd) = zcunxylvaa mytdnbvpvi (vocrhzaxqj )
Positive
01 Aug 2018
ktiztudsaq(ajbnzdfzzd) = xervgyvdcd mytdnbvpvi (vocrhzaxqj )
Phase 3
707
nmmtuxzaoy(bfctrhgmgn) = scvlmjjafv nxiadkhelk (cityqwdwwl, rjvrysdtmy - lwqkwbscfo)
-
23 Jan 2018
Phase 3
226
pvkxcgsvqj(khcawubxua) = siiofpuyhp gjaxwrwlto (qfpxtferwp, gwhhmqclmq - sntuogexxx)
-
07 Apr 2017
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free